HealthPartners Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, HealthPartners Institute sits in the top decile of US sponsors by registered trial count (#191 of 15,742 sponsors by registered trial count).

146 total trials 12 currently recruiting 111 completed early-phase tilt top decile by trial count

HealthPartners Institute: 146 sponsored US clinical trials, 12 recruiting.

HealthPartners Institute sponsors 146 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 111 completed. 11 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 3 trials.

Top-decile sponsor footprint

HealthPartners Institute ranks in the top decile of sponsors by registered trial count (#191 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

111 of 126 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

146 total, page 2 of 3

TERMINATED Phase 2

IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase

NCT04028960

TERMINATED NA

EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock

NCT04134624

TERMINATED Phase 2

Intranasal Insulin in Frontotemporal Dementia (FTD)

NCT04115384

COMPLETED Early Phase 1

Lavender vs Zolpidem Sleep Quality During Diagnostic PSG

NCT04102345

COMPLETED NA

Fuzzy Logic Automated Insulin Regulation

NCT03040414

COMPLETED NA

Simulation of Adenosine Push Methods for Treatment of SVT Using Agitated Saline Visualized by Ultrasound

NCT04051541

COMPLETED NA

Comprehensive Cardiac Rehabilitation Feasibility After Stroke

NCT03944668

COMPLETED NA

Chronic Kidney Disease Clinical Decision Support

NCT03890588

COMPLETED NA

Engaging Patients in Tobacco Cessation Resources in Dental Settings

NCT03656874

COMPLETED

Effect of Prophylactic Negative Pressure Versus Silver Impregnated Silicone Bandage on C-Section Infection Rates

NCT04582045

COMPLETED

Mindfulness Based Dementia Care Study

NCT04062227

TERMINATED

Firefighter Cardiorespiratory Fitness (CRF) Pilot Study

NCT03585335

COMPLETED NA

Cancer Prevention Clinical Decision Support

NCT02986230

COMPLETED NA

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

NCT03657849

COMPLETED NA

Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR

NCT03559179

COMPLETED NA

Audio Distraction for Traction Pin Placement

NCT05927480

COMPLETED NA

Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners

NCT03483025

COMPLETED

Evaluation of a Quality Improvement Project on Impacted Fetal Head at Cesarean Section

NCT03387189

COMPLETED NA

Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure

NCT02996565

COMPLETED Phase 4

Esophageal Food Impaction

NCT03305848

COMPLETED NA

The SIM-PLICITY Study: The SIMulation Project - LIstening & Intervention in Pediatric obeSITY

NCT02946515

COMPLETED NA

EHR-based Decision Support for Pediatric Acute Abdominal Pain in Emergency Care

NCT02633735

COMPLETED

Microbiome Changes in Severe Burns

NCT03130868

COMPLETED NA

Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology

NCT03036215

COMPLETED

Patient Knowledge of Medication Indication

NCT03125278

TERMINATED NA

Single-Stage Integra Reconstruction in Burns

NCT03077087

COMPLETED Phase 4

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

NCT03064035

COMPLETED NA

Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access

NCT03063996

COMPLETED NA

Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)

NCT02759055

COMPLETED Phase 4

Olanzapine for Acute Headaches

NCT03066622

COMPLETED NA

Reducing Cardiovascular Risk in Adults With Serious Mental Illness

NCT02451670

COMPLETED Phase 4

Mirabegron in Parkinson Disease and Impaired Cognition

NCT02536976

TERMINATED Phase 2

Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease

NCT02503501

COMPLETED

Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)

NCT02992327

COMPLETED NA

Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study

NCT02591628

COMPLETED NA

BestFIT: a Personalized Weight Loss Program

NCT02368002

COMPLETED Phase 1

Investigation of the Safety of Intranasal Glulisine in Down Syndrome

NCT02432716

COMPLETED NA

Let's Play! Healthy Kids After Cancer

NCT02361047

TERMINATED NA

Evaluating the Efficacy of Lateral Heel Wedges of Osteoarthritis of the Knee

NCT02254473

TERMINATED NA

Superior Labral Tear From Anterior to Posterior (SLAP) Repair Versus Biceps Tenodesis for SLAP Tears in the Shoulder

NCT02296554

COMPLETED NA

Electronic Health Record-Based Clinical Decision Support to Improve Blood Pressure Management in Adolescents

NCT01760239

COMPLETED NA

Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)

NCT02074384

COMPLETED NA

Intraosseous Pressure Monitoring in Intensive Care Unit Patients

NCT02059928

COMPLETED Phase 4

Sub-dissociative Ketamine for the Management of Acute Pediatric Pain

NCT01951963

COMPLETED Phase 4

Continuous Lidocaine Infusion for Management of Perioperative Burn Pain

NCT02059902

COMPLETED NA

Managing Diabetes Mindfully Study

NCT01796834

COMPLETED Phase 2

Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

NCT01509079

COMPLETED NA

SUPREME-DM (Diabetes Mellitis) Treatment Study

NCT02192255

COMPLETED Phase 2

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

NCT01436045

COMPLETED Phase 4

Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique

NCT02256891

← Previous Page 2 of 3 Next →

What is open in the HealthPartners Institute pipeline

12 recruiting of 146 indexed (8% open); 111 completed (76%).

Phase mix: 11 late (III/IV) vs 19 early (I/II) (early-phase heavy).

Top condition: Type 2 Diabetes (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

HealthPartners Institute: open-pipeline peers nationwide

Peers matched on 146 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

HealthPartners Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 0%5%10%15% Total trials Recruiting share HealthPartners InstituteMylan PharmaceuticalsSCRI Development InnovationsForest LaboratoriesNational Institute of Environmental Health Sciences (NIEHS)National Eye Institute (NEI)Acrotech BiopharmaAtlanta VA Medical CenterBeacon Therapeutics
HealthPartners Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

HealthPartners Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 146 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

What to do with this HealthPartners Institute page

146 registered trials is a research-attention snapshot, not an endorsement of HealthPartners Institute or any single study.

  • 12 of HealthPartners Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Type 2 Diabetes is the condition HealthPartners Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

HealthPartners Institute pipeline card: 146 registered trials from official public datasets.Report a data error.